Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.47%240.14B | -2.96%922.52B | -2.33%229.87B | 4.93%950.66B | 3.22%236.95B | 7.14%241.75B | 5.06%236.61B | 4.32%235.35B | 10.28%906.03B | 11.24%229.56B |
| Cost of revenue | 4.26%203.06B | -3.84%799.98B | -5.88%194.77B | 1.52%831.94B | -0.98%207.17B | 2.09%209.78B | 0.83%208.06B | 4.27%206.93B | 14.98%819.5B | 12.56%209.22B |
| Gross profit | 5.64%37.08B | 3.21%122.54B | 23.51%35.09B | 37.21%118.73B | 46.43%29.79B | 58.53%31.97B | 51.26%28.55B | 4.70%28.42B | -20.51%86.53B | -0.75%20.34B |
| Operating expense | 1.69%21.99B | 4.08%88.34B | 3.57%21.63B | 7.26%84.87B | 8.97%23B | 3.90%19.83B | 7.16%21.17B | 8.83%20.88B | 5.87%79.13B | 3.56%21.1B |
| Operating profit | 11.99%15.08B | 1.04%34.2B | 78.77%13.47B | 357.63%33.85B | 991.21%6.79B | 1,020.20%12.14B | 941.00%7.38B | -5.28%7.53B | -78.32%7.4B | -756.90%-762M |
| Net non-operating interest income (expenses) | 16.17%-534M | -30.19%-2.75B | -86.26%-637M | -133.41%-2.11B | -28.38%-570M | -222.93%-507M | -200.43%-691M | -368.49%-342M | -118.89%-904M | -174.07%-444M |
| Non-operating interest income | -11.01%299M | 7.69%1.51B | 42.37%336M | 183.27%1.41B | 259.49%568M | 122.30%309M | 194.95%292M | 136.00%236M | 34.05%496M | 90.36%158M |
| Non-operating interest expense | -14.39%833M | 21.19%4.26B | 68.34%973M | 151.07%3.52B | 89.04%1.14B | 175.68%816M | 198.78%983M | 234.10%578M | 78.80%1.4B | 145.71%602M |
| Net investment income | -72.61%1.04B | -63.05%2.87B | -4.47%3.8B | 126.20%7.76B | 128.43%3.26B | 32.15%-1.44B | 456.98%1.96B | 5.63%3.98B | -33.43%3.43B | -41.69%1.43B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 5.77B | -54.79%718M | 1.59B | 0 | ||||||
| Income from associates and other participating interests | 2,189.58%1.1B | 127.19%3.71B | -92.60%48M | -75.96%1.63B | -33.99%270M | -46.18%423M | -90.51%291M | -74.36%649M | -13.83%6.79B | -80.19%409M |
| Special income (charges) | 1,582.17%1.91B | 3.75%-7.86B | 37.07%-129M | -476.34%-8.16B | -2,103.52%-7.51B | 33.44%-205M | 68.84%-1.42B | 88.12%-341M | ||
| Less:Other special charges | -1,582.17%-1.91B | -58.81%895M | -37.07%129M | 53.46%2.17B | 347.51%1.53B | ---- | ---- | -33.44%205M | -37.89%1.42B | -43.82%341M |
| Less:Write off | ---- | 16.23%6.96B | ---- | --5.99B | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 957.75%609M | 781.17%1.52B | -129.22%-71M | 85.44%-223M | 50.51%-1.41B | 17.13%1.3B | -260.00%-360M | -18.46%243M | -805.99%-1.53B | -695.24%-2.84B |
| Income before tax | 51.57%24.98B | -5.60%32.42B | 38.98%16.48B | 149.38%34.34B | 195.10%2.42B | 2,590.69%11.27B | 407.16%8.78B | -16.30%11.86B | -77.09%13.77B | -114.53%-2.55B |
| Income tax | 70.10%7.87B | -23.42%7.9B | 43.86%4.63B | 234.51%10.31B | 669.12%3.48B | 128.17%1.47B | 1,116.48%2.14B | 11.90%3.22B | -77.33%3.08B | -111.83%-612M |
| Net income | 44.34%17.11B | 2.04%24.52B | 37.16%11.86B | 124.82%24.03B | 45.28%-1.06B | 4,417.18%9.8B | 326.65%6.64B | -23.47%8.64B | -77.01%10.69B | -115.66%-1.94B |
| Net income continuous operations | 44.34%17.11B | 2.04%24.52B | 37.16%11.86B | 124.82%24.03B | 45.33%-1.06B | 4,417.18%9.8B | 326.93%6.64B | -23.48%8.64B | -77.01%10.69B | -115.66%-1.94B |
| Noncontrolling interests | 11.05%593M | 125.03%2.12B | 184.04%534M | 191.95%943M | -12.66%69M | 401.47%410M | 86.49%276M | -18.97%188M | -84.38%323M | -75.08%79M |
| Net income attributable to the company | 45.90%16.52B | -2.98%22.39B | 33.91%11.32B | 122.74%23.08B | 44.05%-1.13B | 10,418.68%9.39B | 351.88%6.37B | -23.57%8.45B | -76.67%10.36B | -116.73%-2.02B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 45.90%16.52B | -2.98%22.39B | 33.91%11.32B | 122.74%23.08B | 44.05%-1.13B | 10,418.68%9.39B | 351.88%6.37B | -23.57%8.45B | -76.67%10.36B | -116.73%-2.02B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 62.49%105.99 | 3.00%134.05 | 40.10%65.23 | 128.05%130.15 | 51.49%-5.39 | 10,812.00%53.56 | 356.44%35.42 | -23.57%46.56 | -76.28%57.07 | -116.77%-11.11 |
| Diluted earnings per share | 62.49%105.99 | 3.00%134.05 | 40.10%65.23 | 128.05%130.15 | 41.50%-6.4991 | 10,786.76%53.56 | 356.44%35.42 | -23.57%46.56 | -76.28%57.07 | -116.77%-11.11 |
| Dividend per share | 0 | 1.11%91 | 0 | 1.12%90 | 0.00%45 | 0 | 2.27%45 | 0 | 1.14%89 | -30.77%45 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |